SCV Portrait Factsheet Word accessible template



Expression of interest information packCritical Care Clinical NetworkStandardised inotropes and vasopressors: Implementation pilotsubcommittee groupProject backgroundThe Critical Care Clinical Network (CCCN) works with critical care clinicians to improve the quality of care and patient experiences in Victorian critical care Units (ICU/HDU/Critical Care Units). A key priority area for CCCN is to reduce variation in clinical practice and improve consistency of care. A method identified to achieve this is through the use of standardised guidelines. In 2016, the Victorian ICUs identified the need to standardise the central administration of inotropes and vasopressors. Standardisation of inotropes and vasopressors will aid in reducing medication error and as such patient harm. It will also benefit clinicians through ensuring access to up-to-date evidence based guidelines and reducing the need for unit’s to create or review their guidelines. Moreover, it will reduce staff training and potential confusion for those who work across multiple sites. The project is currently in phase three - implementation phase. This will involve four pilot hospitals (inner metro, outer metro, private and regional) being provided with change management strategies, support and resources to implement:Nine inotropes and vasopressors guidelinesAs well as review:Inotropes and vasopressors learning package: a resource used by Liverpool ICU (NSW) and endorsed by the Agency for Clinical Innovation (ACI). It outlines physiology relevant to inotrope and vasopressor use, the clinical indication and mechanism of action for commonly used inotropes and vasopressors, how to calculate drug doses for these and learning activities. Purpose of the subcommittee groupTo be an expert group that guides, monitors and supports the Standardised inotropes and vasopressors: Implementation pilot. Objectives of the subcommitteeThe subcommittee objectives are to:utilise their expertise to support the Clinical Fellow in ensuring effective implementation of the pilotsupport pilot sites in the implementation of the guidelines and learning package through enhancing their ability to apply change management and quality improvement principles review the pilot measures and results (see Appendix 1) promote the Standardised inotropes and vasopressors: Implementation pilot with critical care clinicians across Victoriaprovide advice on upscaling the project on completion of the pilot.Subcommittee Terms of Reference The subcommittee operates under the following terms of reference:encourage the generation of new ideas and the sharing of local innovation in quality improvementcollaborate with peers and relevant bodies to promote and enable the effective implementation of the pilot identify recommendations for participating project sites to best achieve outcomes and provide strategies if sites have difficultiessubcommittee members may also be required to undertake actions between meetings.Subcommittee compositionThe subcommittee will consist of the following types of members:ICU clinicians of all levels i.e. we want clinicians of varying experience levels to bring their expertise to the project e.g. new graduate nurses, ICU registrars, pharmacists, nurse educators etc. members from Ambulance Victoria / Adult Retrieval Services Victoriamembers from the Critical Care Clinical Network and Safer Care VictoriaConsumers.Length of membershipThe appointment will be for the length of the pilot from 19 June – 8 November 2018.Responsibilities of subcommittee members Subcommittee members are expected to: actively contribute in meetings and network activities bring ideas and local innovation to the subcommittee’s attention following consultation with peers, and other health professionalspromote the project within their department and organisationsubmit an apology to the secretariat if unable to attend sign a confidentiality agreementproxy representatives will be considered.Time commitment: meetings The expectation is that subcommittee members will attend 4 x 2 hour meetings during the pilot (see timeline with subcommittee times highlighted in Appendix 2). The dates of the meetings are:19 June12 July21 August8 November.The subcommittee meetings will have a prescribed structure, outlining the purpose and action plans for each meeting. The proposed process will cover structured topics for each meeting with outcomes to be achieved. A quorum is achieved with 50 per cent plus one of members in attendance at a meeting within 20 minutes of the scheduled commencement time of the meeting.Members will not reveal any confidential or proprietary information entrusted in the course of their duties. Upon cessation of membership, and thereafter, the member shall not reveal any confidential or proprietary information, which they obtained while a member of the subcommittee, and may not use or retain, or attempt to use or retain, any such information, documents or data (see separate confidentiality form).How to applyThe CCCN is seeking expressions of interest (EOI) from individuals to be part of the subcommittee for the Standardised inotropes and vasopressors: Implementation pilot. To participate in the subcommittee, please complete the following by COB 8 June 2018 and email to criticalcare.clinicalnetworks@safercare..au:Complete the EOI form which outlines your background, interest and the relevant experience you’ll bring to the plete the Confidentiality and conflict of interest form.Frequently asked questionsWho is Safer Care Victoria?Safer Care Victoria (SCV) is the state’s healthcare quality and safety improvement agency. SCV works with consumers, families and carers, clinicians and health services to monitor and improve the quality and safety of care delivered across our health system.Relevant publicationsSCV Strategic plan 2017–2020SCV Corporate plan 2017–2018 HYPERLINK "" SCV framework for Clinical Networks HYPERLINK ""Clinicians as partners: A framework for clinician engagementWhat is Safer Care Victoria’s relationship with the Department of Health and Human Services?SCV is an administrative office Administrative Office of the Department of Health and Human Services.Under section 14(1) of the Public Administration Act 2004, an Administrative Office head is responsible to the Secretary in relation for the general conduct and effective management of the functions and activities of the Administrative Office. At a functional level, SCV provides advice to the department on clinical quality and the safety implications of policy, planning and funding decisions. What are the SCV Clinical Networks?Our 11 Clinical Networks link SCV with clinicians in health and community services, drawing on their expertise to drive improvements. They play an important role in supporting high quality healthcare, which is person-centered, safe and effective.-103505-645160Maternity and Newborn Clinical NetworkStroke Clinical NetworkCritical Care Clinical NetworkPalliative Care Clinical NetworkPaediatric Clinical NetworkCardiac Clinical NetworkEmergency Clinical NetworkOlder People Clinical NetworkRenal Clinical NetworkInfection Clinical Network Mental Health Clinical Network0Maternity and Newborn Clinical NetworkStroke Clinical NetworkCritical Care Clinical NetworkPalliative Care Clinical NetworkPaediatric Clinical NetworkCardiac Clinical NetworkEmergency Clinical NetworkOlder People Clinical NetworkRenal Clinical NetworkInfection Clinical Network Mental Health Clinical NetworkThe Clinical Networks are tasked with:identifying and implementing care that is supported by the best available researchimproving the quality and safety of care delivered to patients monitoring the performance of health services over timeproviding advice to SCV and the Department of Health and Human Services. Each clinical network has a Governance committee, an INSIGHT (data and evidence) subcommittee and various other working groups that will provide clinical leadership, expertise and advice to SCV. A core principle for the Clinical Networks is to always act in the best interests of consumers and the wider Victorian community. As part of our commitment to consumer representation, we include consumers and/or carers on each of our Clinical Network’s Governance, INSIGHT committees and expert working groups. We need consumer representatives from throughout regional, rural and metropolitan Victoria. Teleconferencing options are supported.To ensure consumers are able to contribute as true partners in Clinical Network activities, all consumer representatives will be provided with appropriate orientation on commencement. Q. What is the Critical Care Clinical Network (CCCN)The Critical Care Clinical Network (CCCN) consists of the 40+ public and private critical care units across regional and metropolitan Victoria.The network is governed by a multidisciplinary steering committee led by Clinical Advisors Associate Professor Nerina Harley and Associate Professor Graeme Hart. The steering committee held its inaugural meeting in September 2015. The CCCN is supported by a program manager, Monica Holdsworth.The Critical Care Clinical Network (CCCN) works with intensive care clinicians to improve the quality of care and patient experiences in Victorian critical care units. The CCCN operates across organisational boundaries to facilitate and support quality improvement activities to improve critical care. The network promotes sharing of innovation, knowledge and information with clinicians to spread local innovations and encourage continuous learning.?What is the Governance committee?The Clinical Network governance committees represent the consumer and clinician member interests, and provide a mechanism for making decisions as well as an avenue for two-way information exchange with SCV. What is the INSIGHT subcommittee?The Clinical Network INSIGHT subcommittees facilitate the identification and use of meaningful clinical data. Specific to this committee is the ability to identify, analyse and interpret data and use this information to participate in decision-making processes to inform the work of the clinical network.What are the expert working groups?Subcommittees or working groups will be mobilised to address specific issues and are considered an important engagement strategy for the networks. Appendix 1Standardised inotropes and vasopressors: Implementation pilot – outcome measures Pilot baseline/ outcome measures (requires multidisciplinary consultation)All ICU / Critical Care Units need to collect the following measures pre and post the pilot:Measure 1: Current ICU/ Critical Care Unit’s inotropes and vasopressors guidelines/current practice Measure 2:.Smart pump drug library entries for inotropes and vasopressors (if applicable) Measure 3: Confidence rating for change process Measure 4: Live bed side data collection of the following (de-identified data) indication for inotrope/vasopressorconcentration of inotrope/vasopressordose of inotrope/vasopressorMeasure 5: Reason for variation from provided guidelines (if applicable) Number required in pre-data and post dataset: Measure 4 to be collected for up to 5 patients on adrenaline and noradrenaline and up to 2 for the remaining inotropes and vasopressorsNB. If site doesn’t use all the listed inotropes and vasopressors in the guidelines or doesn’t reach the provided number, collect the data for as many possible.0997331000Appendix 1 (cont.)Standardised inotropes and vasopressors: Implementation pilot – data collection formDateInfusion Medication356425515049500232646714795500906145-381000Adrenaline Dobutamine Dopamine 35674301568450023228301625600092329016573500Isoprenaline Levosimendan Metaraminol 356362014033500232410015811500 903605-889000 Milrinone Noradrenaline Vasopressin PreparationAs recorded on current infusion bag/syringe250639384455010782307810501847823770 in ml of Total dose volume fluidCurrent dosage being administered mcg/minmg/min mL/hr (from pump/fluid balance chart)Other (specify units)unit/hrWhy is the patient receiving this infusion?1651013208000 Decreased Blood Pressure 1333516256000 Decreased Heart Rate15875889000 Decreased Cardiac Output 4780971294820Other: Was there a variation in practice from the guideline currently in use in the unit? 1284605-1524000408305000Yes No If answered “Yes”, please provide a reason below:44451250954445222254445946154445147955444535560444598425Appendix 2Standardised inotropes and vasopressors: Implementation pilot – timelineActivityMayJunJulAugSepOctNovEOI released18ICUs prepare EOIICU identifies if ethics approval is requiredICU collects information and data to identify evidence practice gapICUs submit EOI 1CCCN Steering Committee reviews EOIsCCCN notifies ICU of participation 15Subcommittee Meeting 1: overview of pilot, hospitals involved and chosen project measures19“Kick Off” Webinar20Pilot starts 25ICUs collect pre data256ICUs submit draft project plan + pre data(template will be provided) 6Implementation Science Workshop10Pre- implementation phase: ICUs plan, develop and test changes to address the practice gap on a small scale103Subcommittee Meeting 2: review data from sites, review their current performance 12Teleconference (All sites TBC)Implementation phase: ICUs implement and continue to refine the change on a large scale i.e. across the unit624Site visits (individual site dates TBC)Subcommittee Meeting 3: ongoing review of sites performance. Identify if subcommittee members to attend site visits21ICUs submit post data28Post implementation Workshop 2ICUs submit end of project report 12CCCN analysis on post data and provides feedback to ICUs at sector wide forum. Develops and circulates final report 31Subcommittee Meeting 4: review of final project report, discussions on further spread / statewide implementation of project8 ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download